Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Neupogen
Neupogen
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Amgen
Neupogen
Zarxio
Novartis
biosimilars
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz
Novartis AG's 'biosimilar' drug sale blocked by U.S. appeals court
Yahoo/Reuters
Thu, 05/7/15 - 09:38 pm
Novartis
biosimilars
Neupogen
Amgen
Amgen motion to delay Neupogen biosimilar denied
Medical Marketing and Media
Fri, 04/17/15 - 08:44 am
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Amgen loses another round in its battle to fend off a biosimilar rival
Marketwatch
Mon, 03/30/15 - 09:23 pm
Amgen
biosimilars
Neupogen
Zarxio
Novartis
Denied Again! Another Obstacle to Biosimilar First Launch Falls with FDA Rejection of Amgen’s Certification Petition
FDA Law Blog
Fri, 03/27/15 - 08:39 am
Amgen
biosimilars
FDA
Sandoz
Neupogen
Zarxio
Amgen to appeal rejection of bid to block Novartis biosimilar drug
Yahoo/Reuters
Wed, 03/25/15 - 03:18 pm
Amgen
Novartis
Neupogen
biosimilars
Zarxio
U.S. judge rejects Amgen injunction bid against Novartis Sandoz unit
Yahoo/Reuters
Fri, 03/20/15 - 11:00 am
Amgen
Neupogen
Novartis
Sandoz
biosimilars
Amgen: The biotech that's getting on the biosimilar R&D bandwagon
BioPharma Dive
Wed, 03/11/15 - 08:38 am
Amgen
biosimilars
Zarxio
Neupogen
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Amgen
biosimilars
Roche
AbbVie
Neupogen
First-ever bio-generic drug doesn’t help Novartis shares
Marketwatch
Sun, 03/8/15 - 10:20 am
biologics
Novartis
Neupogen
Zarxio
First Copycat Biotech Drug Spurs $250B Obamacare Savings
Forbes
Sat, 03/7/15 - 11:16 am
Zarxio
Novartis
biologics
Amgen
Neupogen
Novartis gets bragging rights on first U.S. biosim. But will its Neupogen copy sell?
Fierce Pharma
Fri, 03/6/15 - 11:27 am
Novartis
Neupogen
Zarxio
biosimilars sector
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Novartis AG, Amgen, Inc. Tussle Over Neupogen Biosimilar Continues
Bidness Etc.
Sun, 03/1/15 - 11:40 am
Novartis
Amgen
biosimilars
Neupogen
Amgen, Inc. Files Petition To Stop Novartis (NVS) From Launching Neupogen Bilosimilar
Bidness Etc.
Tue, 02/10/15 - 08:38 am
Amgen
Novartis
Neupogen
biosimilars
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
FDA
advisory panels
biosimilars
Neupogen
Amgen
Novartis
Sandoz
FDA staff recommends Novartis copy of Amgen's Neupogen
Yahoo/Reuters
Mon, 01/5/15 - 09:29 am
FDA
Amgen
Novartis
Neupogen
biosimilars
breast cancer
Zarzio
chemotheraphy-induced neutropenia
Pages
« first
‹ previous
1
2
3
next ›
last »